forecast

Single-Payer Wouldn't Hurt Health Outcomes

Because drug companies are not the drivers of innovation, a global shift to single-payer systems that use negotiating leverage to cut drug prices would lower industry profits with no negative impact on health outcomes.

forecastpending

Speaker

Marcia Angell

Evidence Quote

“Minimum, negative impact. I would say no negative impact. Absolutely.”

Source

Marcia Angell on Big Pharma— EconTalk
Created: 6/13/2026, 12:08:22 AM

Your notes

Loading notes...